Why now
Clinical AI is crossing from suggestion to dependence at the same moment regulators are deciding what evidence they will require. The standard gets set in this window.
Home Investors
The bottleneck moved from capability to verifiability.
Almost all the capital in healthcare AI is going into making models more capable. Very little is going into the far less glamorous question of how anyone establishes that a particular output is correct. That gap is the company.
The thesis
Capable is not the same as deployable.
Clinically impressive products stall — not because the model is weak, but because a health system cannot deploy what it cannot govern, a safety committee cannot approve what it cannot inspect, and a clinician will not rely on what they cannot check.
Today the evidence offered to those gatekeepers is produced by the vendor being assessed. That is a company grading its own exam. It slows good products down and lets weak ones through, and no amount of model improvement fixes it, because the problem is structural rather than technical.
Verification does not compress into a model call. It needs credentialled people, structured judgement, evidence linking and records that survive scrutiny years later. Building that once, as infrastructure, so every clinical AI company does not assemble it alone — that is the work, and it is the kind of work that compounds.
Why independent
Verification means something only when the party doing it has no stake in the answer being yes. That rules out the incumbents and the model providers — which is the defensible position.
Why healthcare first
It is the domain with the least tolerance for a confident wrong answer. A standard that holds here transfers to every other high-stakes field. Solve it where it is hardest.
Business model
How the business makes money.
Four streams, all from the same operation. Every verification performed is simultaneously a sale, a margin, and a labelled data point.
Per-case verification
Priced from specialty, complexity and clinical risk, with the reviewer paid a share of each case. Margin is structural rather than negotiated. Pricing.
Continuous monitoring
A monthly platform fee plus volume. Recurring, and it grows with the customer's own usage rather than with headcount.
Enterprise agreements
Multi-year contracts with custom rubrics, named reviewer panels, SLAs with remedies and deeper integration.
Evaluation datasets
Reviewed cases carry expert corrections, hallucination labels and risk assessments — the rarest category of medical training data. Licensed only with the originating customer's written agreement.
Why the data compounds
Conventional dataset businesses pay experts to label. Here a customer pays for the review, the reviewer is paid from that revenue, and the labelled example remains — so the corpus is a by-product of a profitable operation rather than a cost centre.
That is the flywheel: more customers produce more reviewed cases, which make the evaluation datasets more valuable, which funds a deeper reviewer network, which shortens turnaround, which wins more customers.
- Expert-corrected content, not crowd annotation
- Hallucination labels — the scarcest signal in medical AI evaluation
- Risk assessments usable for safety tuning
- Licensed by consent, never harvested by default
What is hard to copy
Defensibility
A credentialled reviewer network across specialties takes years to recruit and cannot be bought quickly. Neither can a history of reviewed cases.
The position that is hardest to copy is not technical. It is being the party with no stake in the verdict — which the model providers and the vendors structurally cannot occupy.
Where we are
Stated plainly.
The rest of this site publishes what the company does not claim. That discipline applies here too — an investor page is exactly the wrong place to relax it.
-
Built
The engines
Classification, specialty matching, pricing, the six-dimension review rubric, report scoring, expert lifecycle enforcement and per-payment checkout — implemented, tested and open in the repository.
-
Built
The public platform
Marketing site, live pricing simulator running the real engine, published admission criteria for reviewers and partners, and a consent layer that blocks non-essential storage before a visitor chooses.
-
In progress
Portals and the API
The customer, reviewer and administrator surfaces, and the HTTP layer that connects them to the engines. Authorisation policy is written and tested ahead of the routes it protects.
-
Next
Design partners
Real cases from real clinical AI products, producing the first measured baselines — and the first reviewed corpus.
Investor enquiries
Request the materials.
Detailed materials — model, projections, cap table and roadmap — go out under NDA following a short conversation with the founder.
Founder
Harmony Verify was founded by Affriee Darele Yvana, who has spent years at the intersection of healthcare and technology and watched deployment speed outpace verification. Her account of why the company exists is worth reading before a first call.
Diligence
The engines, the rubric, the pricing formulas and the enforcement rules are in a public repository with a test suite. You can read how the thing actually works before anyone shows you a slide.